Dual-Targeted Therapy with Ruxolitinib Plus Duvelisib for T-Cell LymphomaAlison J. Moskowitz, Sarah McCue Horwitz, Nivetha Ganesan et al.|Blood|2024Cited by 10
Development and Validation of a Mixed-Reality Simulator for Reducing Biopsy Core Deviation During Simulated Freehand Systematic Prostate BiopsySamsun Lampotang, Thomas Stringer, Anthony DeStephens et al.|Simulation in Healthcare The Journal of the Society for Simulation in Healthcare|2023Cited by 4
Immune Signature of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin As Second-Line Therapy for Relapsed or Refractory Classical Hodgkin LymphomaBeatriz Wills, Alison J. Moskowitz, Nivetha Ganesan et al.|Blood|2022Cited by 0